About SurgVision
SurgVision is a Healthcare company based in Hardenberg (Netherlands) founded in 2013, and was acquired by Bracco in October 2017. Fluorescent platform technology is developed for surgical tumor guidance. SurgVision offers products and services including EXPLORER AIR II, BEVA800 TM, and EXPLORER FLUOSCOPE. Its focus areas include Life Sciences, Surgical Instruments and Navigation Systems. Its legal entity is SurgVision GmbH.
Company details
SurgVision was founded in 2013 in Hardenberg, Netherlands, within the medical technology sector. Platform technology for fluorescent guidance in tumor surgeries is developed, utilizing tracers and Multi-Spectral Normalized Imaging to detect malignant tissues across multiple wavelengths while correcting optical distortions. Clinical trials reached Phase II by June 2017, targeting applications such as breast cancer, peritoneal carcinomatosis, rectal cancer, esophageal lesions, and adenomatous colon tissue.
- Headquarters Hardenberg, Netherlands
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website surgvision.com
- Acquired by Bracco (Oct 2017)
- Legal Name Surgvision Gmbh
Products & Services of SurgVision
SurgVision offers a comprehensive portfolio of products and services, including EXPLORER AIR II, BEVA800 TM, and EXPLORER FLUOSCOPE.
Intra-operative system for real-time fluorescence visualization in surgery
Agent for labeling cancer lesions during oncology procedures
Prototype for interventional oncology fluorescence imaging
Investors in SurgVision
SurgVision has secured backing from 1 investor. Prominent investors backing the company include Bracco.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Diagnostic imaging is advanced by Bracco through contrast enhancement techniques. | 1927 | bracco.com | Milan, Italy |
Investor details for SurgVision
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of SurgVision
2 dated milestones of SurgVision across 4 years, from founding to its latest funding, stage changes and deals.
- Founded SurgVision is founded.
- Exit Acquired by Bracco.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Surgvision
Complete news archive for SurgVision
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SurgVision
SurgVision was founded in 2013.
SurgVision is headquartered in Hardenberg, Netherlands. It is registered at Hardenberg, Overijssel, Netherlands.
SurgVision was founded in 2013 in Hardenberg, Netherlands, within the medical technology sector. Platform technology for fluorescent guidance in tumor surgeries is developed, utilizing tracers and Multi-Spectral Normalized Imaging to detect malignant tissues across multiple wavelengths while correcting optical distortions. Clinical trials reached Phase II by June 2017, targeting applications such as breast cancer, peritoneal carcinomatosis, rectal cancer, esophageal lesions, and adenomatous colon tissue.
SurgVision offers EXPLORER AIR II, BEVA800 TM, and EXPLORER FLUOSCOPE.
SurgVision has 1 investor. Key investors include Bracco.
SurgVision operates through Surgvision Gmbh.
Yes. SurgVision was acquired by Bracco in October 2017.